A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
Public ClinicalTrials.gov record NCT03835884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
First-in-Human Study of the Safety of AR-13503 Sustained Release Intravitreal Implant in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) and Subjects With Diabetic Macular Edema (DME)
Study identification
- NCT ID
- NCT03835884
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Aerie Pharmaceuticals
- Industry
- Enrollment
- 18 participants
Conditions and interventions
Interventions
- AR-13503 42.4 Dose Drug
- AR-13503 63.6 Dose Drug
- AR-13503 Implant 10.6 Dose Drug
- AR-13503 Implant 21.2 Dose Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2019
- Primary completion
- May 11, 2022
- Completion
- May 11, 2022
- Last update posted
- Feb 8, 2023
2019 – 2022
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute, LLC | Gilbert | Arizona | 85296 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | — |
| Sterling Vision, PC dba Oregon Retina | Eugene | Oregon | 97401 | — |
| Valley Retina Institute, P.A. | Harlingen | Texas | 78550 | — |
| Medical Center Ophthamology Associates | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03835884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03835884 live on ClinicalTrials.gov.